The immunotherapy technology developer has set a $230m target for an initial public offering that would offer exits to LabCorp, Illumina, Celgene and BD Biosciences.

TransUnion-backed digital identity management platform Dashlane added $110m in a Sequoia Capital-led round to take its funding to more than $185m to date.

Novo, GlaxoSmithKline, Pfizer, AbbVie, ShangPharma and Schrödinger are all in line for exits following the small-molecule drug developer's decision to file for an $86.3m initial public offering.

Fiserve took part in the $82.5m round, which increased BlueVoyant's total funding to $207m, valuing cybersecurity services provider at more than $430m.

The capital management platform has added $10m to a series B round featuring Salesforce, National Grid and Wells Fargo that now stands at $34m.

The data beaming software provider will use the proceeds from the GE Ventures-backed round to expand in Europe and create a partner network.

The healthcare data integration platform received $12.7m in a round featuring corporate joint venture Echo Health Ventures, which took part as an existing investor.

Merck Group's M Ventures unit led the research and development software provider's series B round, investing alongside Waters Corporation and existing backer OATV.

The data backup and recovery technology provider has increased a series C round that includes Salesforce Ventures to $23.3m.

MassMutual Ventures took part in the round, which will enable the cloud-based time and billing management software provider to hire more senior management and product development staff.